Quest Diagnostics Incorporated ($DGX) Stock Forecast: Down 2.7% Today

What is Quest Diagnostics Incorporated?

Quest Diagnostics (DGX) is a leading provider of diagnostic testing, information, and services, helping people make better healthcare decisions. The company has been performing well in terms of earnings and revenue.

Why is Quest Diagnostics Incorporated going down?

DGX stock is down 2.7% on Oct 21, 2025 14:35

• Despite surpassing Q3 earnings and revenue estimates, Quest Diagnostics (DGX) experienced a bearish movement in the market today.
• The market might have reacted negatively due to profit-taking by investors after the recent positive performance.
• Investors may have been expecting even higher results, leading to a sell-off post-earnings announcement.
• The stock's strong bearish movement could also be influenced by broader market conditions or sector-specific factors impacting healthcare companies.

DGX Price Chart

DGX Technical Analysis

DGX News

Quest Diagnostics ( DGX ) Surpasses Q3 Earnings and Revenue Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of +3.59% and +3.45%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2772821/quest-diagnostics-dgx-surpasses-q3-earnings-and-revenue-estimates

Will Quest Diagnostics ( DGX ) Beat Estimates Again in Its Next Earnings Report?

Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

https://www.zacks.com/stock/news/2768585/will-quest-diagnostics-dgx-beat-estimates-again-in-its-next-earnings-report

Trending Today

Illumina Inc. ($ILMN) Stock Forecast: Up 25.0% Today

First Solar Inc. ($FSLR) Stock Forecast: Up 13.2% Today

MicroStrategy ($MSTR) Stock Forecast: Up 6.0% Today

DexCom Inc. ($DXCM) Stock Forecast: Down 14.3% Today

Reddit Inc ($RDDT) Stock Forecast: Up 7.8% Today

Cloudflare Inc. ($NET) Stock Forecast: Up 12.5% Today

Amazon.com Inc. ($AMZN) Stock Forecast: Up 10.4% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.6% Today

XRP ($XRP) Crypto Forecast: Up 5.3% Today

Ethereum ($ETH) Crypto Forecast: Up 5.0% Today

Quest Diagnostics Incorporated Price History

30.00.2025 - DGX Stock was up 6.5%

• The company reported strong fourth-quarter earnings and revenue that exceeded analyst expectations, showcasing robust performance in their core business.
• Despite the positive financial results, the stock initially experienced a dip, potentially influenced by profit-taking or short-term market fluctuations.
• Quest Diagnostics' improved margins demonstrate effective cost management and enhanced operational efficiency, which may have contributed to the positive movement in the stock.
• Investors reacted favorably to the company's overall solid financial performance, leading to the bullish market activity observed.

02.09.2025 - DGX Stock was down 5.0%

• Today, despite collaborations with Epic and Rutgers Cancer Institute, DGX encountered a downward movement.
• Speculations suggest the market response could be influenced by overall market trends, sector shifts, or profit collection by traders.
• Some investors might have been anticipating swift financial gains from the partnerships, potentially triggering a temporary stock sell-off.
• Observing the progress of these collaborations is crucial to evaluate their influence on DGX's financial results and stock valuation.

21.09.2025 - DGX Stock was down 2.7%

• Despite surpassing Q3 earnings and revenue estimates, Quest Diagnostics (DGX) experienced a bearish movement in the market today.
• The market might have reacted negatively due to profit-taking by investors after the recent positive performance.
• Investors may have been expecting even higher results, leading to a sell-off post-earnings announcement.
• The stock's strong bearish movement could also be influenced by broader market conditions or sector-specific factors impacting healthcare companies.

19.02.2025 - DGX Stock was down 5.1%

• Quest Diagnostics (DGX) experienced a bearish movement today.
• Aveanna (AVAH) surging 6.2% might have diverted investor attention away from DGX.
• The lack of positive earnings estimate revisions for Aveanna could have prompted investors to move funds out of DGX and into more promising opportunities.
• The shift in focus towards Aveanna's potential gains may have contributed to the bearish movement in Quest Diagnostics (DGX) today.

23.06.2025 - DGX Stock was down 0.6%

• Despite surpassing Q2 earnings and revenue estimates, Quest Diagnostics (DGX) witnessed a bearish market movement.
• The market potentially reacted negatively due to profit-taking by investors following a 3.2% rise in pre-market trading post the positive earnings results.
• Investors might have anticipated higher numbers or future guidance, leading to a sell-off after the earnings announcement.
• The robust historical performance of Quest Diagnostics possibly elevated expectations to a level where meeting estimates was insufficient to maintain the bullish momentum, resulting in today's bearish movement.

22.06.2025 - DGX Stock was up 5.2%

• Over the past 5 years, Quest Diagnostics (DGX) has delivered impressive performance, surpassing the market with an average annual return of 508.21%.
• The positive market movement of Quest Diagnostics is possibly influenced by expectations of beating earnings estimates in the upcoming report.
• Investor sentiment towards Quest Diagnostics remains upbeat due to its solid historical performance and growth potential in the diagnostic testing sector.

21.04.2025 - DGX Stock was down 5.1%

• Today's decline in DGX's stock price could be linked to profit-taking by investors following the recent surge.
• The market reaction might be influenced by broader economic conditions or specific news affecting the healthcare sector, resulting in a temporary downturn for DGX.
• Investors may be reevaluating their positions in DGX after the recent uptrend, causing a short-term decrease in the stock price.

22.03.2025 - DGX Stock was up 7.7%

• Quest Diagnostics (DGX) stock showed a strong bullish movement.
• The company surpassed expectations with its first quarter 2025 earnings and revenues, outperforming analyst projections.
• The stock's upward trend can be attributed to the favorable earnings report and sustained growth over the past 5 years.
• Investor optimism in Quest Diagnostics' performance and market position is likely driving the stock price increase.

22.03.2025 - DGX Stock was up 5.8%

• Strong Q1 earnings and revenues exceeded expectations, signaling robust financial performance and potentially favorable future outlook.
• Over the last 5 years, the stock has consistently outperformed the market, demonstrating steady growth and investor trust.
• Although there was a minor decline in stock price in the past month, the significant rise over the last year indicates sustained positive momentum.
• Anticipated earnings growth is reinforcing the bullish trend, implying ongoing profitability and investor confidence in the company's prospects.

22.03.2025 - DGX Stock was up 8.2%

• Quest Diagnostics (DGX) experienced a robust upward movement today.
• The company exceeded earnings expectations for the first quarter, resulting in a notable surge in its stock price.
• Over the past 5 years, Quest Diagnostics has consistently outperformed, showcasing an impressive average annual return that has likely boosted investor confidence and interest in the stock.
• Strong earnings and revenue results for the quarter ending in March 2025 indicate a solid performance by the company, potentially fueling additional investor confidence and driving the stock price upwards.

22.06.2025 - DGX Stock was up 6.0%

• Quest Diagnostics (DGX) exceeded Q2 earnings and revenue estimates, showcasing a 15.2% revenue growth and a significant EPS beat, leading to a 3.2% rise in the stock price.
• The company's consistent outperformance over the past 5 years, with an impressive annualized return of 508.21%, has likely contributed to investor confidence and positive market sentiment.
• With a history of surpassing earnings expectations and favorable market conditions, Quest Diagnostics (DGX) appears well-positioned to continue its upward trajectory, attracting further investor interest and driving the bullish movement in the stock price.

01.09.2025 - DGX Stock was down 3.7%

• The partnership between DGX's Haystack Oncology and Rutgers Cancer Institute to study the application of ctDNA MRD test in guiding therapy for lung cancer could have raised concerns about the company's current testing methods or future revenue streams.
• Investors might be worried about the potential impact on DGX's market share or competitive position in the oncology diagnostic testing space.
• The market might be reacting to the uncertainty surrounding the outcome of the study and its implications for DGX's future growth prospects in the oncology segment.